Growth analysis published a report describing new opportunities for Swedish life science
The other day Growth Analysis published a report on the subject: ” Rare diseases – an opportunity for Swedish life science”. The report describes and compares prerequisites for, and initiatives in relation to, rare diseases and development of orphan drugs in Sweden, the EU, the USA and a number of countries in Asia.
Read more and download the report External link, opens in new window. (external link, opens in a new window)